Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial
Anne Demols, Ivan Borbath, Marc Van den Eynde, Ghislain Houbiers, Marc Peeters, Raphaël Maréchal, T. Delaunoit, J.-C. Goemine, Stéphanie Laurent, Stéphane Holbrechts, Marianne Paesmans, Jean‐Luc Van Laethem
Topics & Concepts
MedicineRegorafenibGemcitabineChemotherapyInternal medicineOncologyDouble blindColorectal cancerCancerPathologyPlaceboAlternative medicineCholangiocarcinoma and Gallbladder Cancer StudiesBone health and treatmentsAdvanced Breast Cancer Therapies